CerRx
PrivateCompany Overview
CerRx is a biotechnology company that develops anticancer drugs, including Fenretinide and Safingol, designed to increase ceramide levels to selectively kill cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticaloncology therapeuticsdrug discoveryclinical trialssmall moleculecancer researchbiotechapoptosisceramide pathwayshematologic malignanciesdrug developmentfenretinidesafingolpharma licensingclinical-stage
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CerRx Comparables
Compare CerRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SphingoGene, Inc. | 84% | |
| Apogee Biotechnology Corporation | 78% | |
| Bexion Pharmaceuticals | 76% | |
CerRx Funding Rounds
Historical fundraising activity
CerRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CerRx's valuation, stock price, and market status.
See something wrong or outdated?